All In Biotech

Drug Trial Radar · NCT03537508

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

A Phase III, Partially Modified Double-blind, Randomized, Parallel-group, Active-controlled, Multi-center Study to Compare the Immunogenicity and Describe the Safety of MenACYW Conjugate Vaccine and MENVEO® When Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in the United States

Last checked: Nov 20, 2026Latest source record: Oct 15, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,627 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,627

Actual

Start

Apr 25, 2018

Primary completion

Sep 22, 2023

Study completion Sep 22, 2023

Sponsor

Lead sponsor
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
May 25, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 42 days, up to 89 days
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study was to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO® when both are administered concomitantly with routine pediatric vaccines to healthy infants and toddlers in the US.

Conditions

  • Healthy Volunteers (Meningococcal Infection)

Interventions

  • MenACYW conjugate vaccineBiological

    Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid conjugate vaccine 0.5 mL, intramuscular

  • MenACYW-135 conjugate vaccineBiological

    Meningococcal (Groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine, 0.5 mL, intramuscular

  • DTaP-IPV//Hib vaccineBiological

    DTaP-IPV//Hib vaccine at 2, 4, 6 and 12 to 15 (Group 1a)/15-18 (Group 1b and Group 2) months of age Intramuscular

  • Pneumococcal 13-valent conjugate vaccineBiological

    Pneumococcal vaccine at 2, 4, 6, and 12 months of age, Intramuscular

  • Pentavalent rotavirus vaccineBiological

    Rotavirus vaccine at 2, 4, and 6 months of age, oral solution

  • Hepatitis B vaccineBiological

    Hepatitis B vaccine at 2 and 6 months of age, Intramuscular

  • Measles, mumps, rubella (MMR) vaccineBiological

    MMR vaccine at 12 months of age, Subcutaneous

  • Varicella vaccineBiological

    Varicella vaccine at 12 months of age

  • Hepatitis A vaccineBiological

    Hepatitis A vaccine at 15 to 18 months of age

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Groups 1a and 2a: Percentage of Participants With Vaccine Seroresponse Measured by Serum Bactericidal Assay Using Human Complement (hSBA) at Day 30 Post 12-Month VaccinationTime frame: Day 30 post 12-month vaccination (Month 13)
  2. Groups 1 and 2: Percentage of Participants Who Achieved Antibody Titers >=1:8 by hSBA at Day 30 Post 6-Month VaccinationTime frame: Day 30 post 6-month vaccination (Month 7)

Locations

70 sites in 2 countries. Site status is shown where the registry gives one.

  • Birmingham Pediatric Associates Site Number : 8400026

    Birmingham, Alabama

  • Southeastern Pediatric Associates Site Number : 8400003

    Dothan, Alabama

  • MedPharmics, LLC - Phoenix Site Number : 8400083

    Phoenix, Arizona

  • Northwest Arkansas Pediatric Clinic Site Number : 8400011

    Fayetteville, Arkansas

  • The Children's Clinic of Jonesboro, PA Site Number : 8400032

    Jonesboro, Arkansas

  • Emmaus Research Center, Inc Site Number : 8400031

    Anaheim, California

  • Premier Health Research Center Site Number : 8400007

    Downey, California

  • Joint Clinical Trials Huntington Park Site Number : 8400126

    Huntington Park, California

  • United Clinical Research Site Number : 8400092

    Huntington Park, California

  • Matrix Clinical Research Site Number : 8400095

    Los Angeles, California

  • Center for Clinical Trials, LLC Site Number : 8400030

    Paramount, California

  • Center for Clinical Trials of San Gabriel Site Number : 8400076

    West Covina, California

  • Asclepes Research Centers Site Number : 8400064

    Brooksville, Florida

  • Avail Clinical Research Site Number : 8400077

    DeLand, Florida

  • Next Phase Research Alliance Site Number : 8400057

    Hialeah, Florida

  • Homestead Medical Clinic, P.A. Site Number : 8400014

    Homestead, Florida

  • Next Phase Research Alliance Site Number : 8400040

    Homestead, Florida

  • Children's Research, LLC Site Number : 8400063

    Lake Mary, Florida

  • Axcess Medical Research Site Number : 8400068

    Loxahatchee Groves, Florida

  • Acevedo Clinical Research Associates Site Number : 8400001

    Miami, Florida

  • Florida Hospital Medical Group Pediatrics Site Number : 8400108

    Orlando, Florida

  • IMIC Inc Site Number : 8400022

    Palmetto Bay, Florida

  • Jedidiah Clinical Research Site Number : 8400132

    Tampa, Florida

  • Baybol Research Institute Site Number : 8400008

    Chamblee, Georgia

  • Snake River Research, PLLC Site Number : 8400073

    Idaho Falls, Idaho

  • Qualmedica Research, LLC Site Number : 8400106

    Evansville, Indiana

  • Brownsboro Park Pediatrics Site Number : 8400010

    Louisville, Kentucky

  • All Children Pediatrics Site Number : 8400043

    Louisville, Kentucky

  • ACC Pediatric Reasearch Site Number : 8400023

    Haughton, Louisiana

  • Velocity Clinical Research Site Number : 8400025

    Metairie, Louisiana

  • LSUHSC-Shreveport Site Number : 8400120

    Shreveport, Louisiana

  • University of Maryland at The Pediatric Center of Frederick Site Number : 8400004

    Frederick, Maryland

  • Virgo-Carter Pediatrics Site Number : 8400041

    Silver Spring, Maryland

  • MedPharmics Biloxi Site Number : 8400080

    Biloxi, Mississippi

  • Craig Spiegel, MD Site Number : 8400037

    Bridgeton, Missouri

  • Creighton University Site Number : 8400039

    Omaha, Nebraska

  • Tiga Pediatrics Site Number : 8400137

    New York, New York

  • Blue Pediatric & Adolescent Medicine Group Site Number : 8400100

    Boone, North Carolina

  • Ohio Pediatric Research Site Number : 8400084

    Dayton, Ohio

  • PriMed Clinical Research Site Number : 8400002

    Dayton, Ohio

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.